Home

Sandostatin injection

Injecting Sandostatin® LAR

Proper administration technique Administer the injection at a 90º angle Note: Sandostatin ® LAR ® must be given only by deep intramuscular injection, never intravenously. Insert the needle fully into the left or right gluteus at a 90º angle to the ski Sandostatin injection is injected under the skin, into a muscle, or as an infusion into a vein. A healthcare provider will give your first dose and may teach you how to properly use the medication by yourself. Read and carefully follow any Instructions for Use provided with your medicine. Prepare an injection only when you are ready to give it Important Safety Information Warnings and Precautions: Treatment with Sandostatin LAR Depot may affect gallbladder function, with postmarketing reports of gallstones resulting in complications (inflammation of the gallbladder, bi.. Sandostatin ® LAR Depot (octreotide acetate) for injectable suspension is indicated for patients in whom initial treatment with immediate-release Sandostatin ® (octreotide acetate) Injection has been shown to be effective and tolerated for Long-term treatment of the severe diarrhea and f.. Sandostatin is given by subcutaneous injection (the layer of tissue between the skin and the muscle). It may be necessary to take the shot several times a day. The injection sites should be rotated regularly. Sandostatin may also be given intravenously

Octreotide acetate is an injectable medicine that is very similar to the hormone somatostatin, which is naturally produced in the body that has several effects including inhibition of the release of hormones The FDA approved two forms of Sandostatin: immediate-release Sandostatin and extended-release Sandostatin LAR Depot. Immediate release means the drug is released into your body as soon as it's..

Sandostatin ® LAR Depot (octreotide acetate) for injectable suspension is indicated for patients in whom initial treatment with immediate-release Sandostatin ® (octreotide acetate) Injection has been shown to be effective and tolerated fo Applies to octreotide: injectable solution, intramuscular powder for injection extended release, oral delayed release capsule, subcutaneous solution General The most common adverse events were gastrointestinal disorders, nervous system disorders, hepatobiliary disorders, and metabolism and nutritional disorders Find information about which conditions Sandostatin injection is commonly used to treat

Sandostatin ® (octreotide acetate) Immediate-Release Injection and Sandostatin LAR Depot can be used to initiate treatment, titrate treatment, and treat flare-ups Sandostatin® octreotide acetate Injection Rx Only T2002-XX XXXXXXXX as a clear sterile inistration by deep or intravenous injection. Octreotide acetate, known chemically as -lysyl-L- -(R*, R*)] acetate salt, is a long-acting octapeptide with pharmacologic actions mimicking those of the atostatin. Sand sterile 1 mL ampuls in 3 strengths Sandostatin LAR Depot is available in a vial containing the sterile drug product, which when mixed with diluent, becomes a suspension that is given as a monthly intragluteal injection. The octreotide is uniformly distributed within the microspheres which are made of a biodegradable glucose star polymer, D,L-lactic and glycolic acids copolymer Neuroendocrine tumors (NET) arise from cells throughout the nervous and endocrine systems (eg, cells of the pancreas, parathyroid, adrenal, and pituitary glands). They may also arise from the calcitonin-producing cells of the thyroid glands. 1 NET can progress for 5 to 7 years before correct diagnosis 2. Patients with NET may or may not have symptoms caused by hormonal hypersecretion. 2 NET.

Sandostatin: Uses, Dosage, Side Effects, Warnings - Drugs

CMS Internet-Only Manual, Pub 100-02, Medicare Benefit Policy Manual, Chapter 15, §§50-50.4.7 was removed from the CMS National Coverage Policy section of the related Octreotide Acetate for Injectable Suspension (Sandostatin LAR® depot) L33438 and placed in this article Sandostatin® (octreotide acetate) Injection exerts pharmacologic actions similar to the natural hormone, somatostatin. It is an even more potent inhibitor of growth hormone (GH), glucagon, and..

SANDOSTATIN® LAR Depot (octreotide acetate) for Acromegaly

Octreotide comes as an immediate-release solution (liquid) for injection to be injected subcutaneously (under the skin) or intravenously (into a vein) Octreotide also comes as a long-acting injection to be injected into the muscles of the buttocks by a doctor or nurse. Octreotide immediate-release injection is usually injected 2 to 4 times a day Somatostatin is a hormone made naturally in the body. It slows down or stops the production of a number of hormones such as insulin and gut hormones. It also controls the emptying of the stomach and bowel. Octreotide is a synthetic version of somatostatin (a somatostatin analogue) and slows down the production of hormones

Patient Day 201 Octreotide acetate injection may be administered subcutaneously or intravenously. Subcutaneous injection is the usual route of administration of octreotide acetate injection for control of symptoms. Pain with subcutaneous administration may be reduced by using the smallest volume that will deliver the desired dose Sandostatin LAR is a long acting form of Sandostatin injection. It is injected into the buttocks once every 4 weeks, instead of having frequent injections of the short-acting Sandostatin under the skin. Sandostatin LAR is used to treat acromegal Octreotide injection is injected under the skin, into a muscle, or as an infusion into a vein. A healthcare provider will give your first dose and may teach you how to properly use the medication..

Sandostatin® Injection solution given subcutaneously was 60 - 63%. In patients with acromegaly, the octreotide concentrations after single doses of 10 mg, 20 mg, and 30 mg Sandostatin LAR® Depot were dose proportional. The transient day 1 peak, amounting to 0.3 ng/mL, 0.8 ng/mL Sandostatin is a synthetic that mimics the hormone, somatostatin. I agree, it is coded as a therapeutic injection. I've given it as a therapeutic infusion for bleeding esophageal varices as an off label treatment In clinical trials with Sandostatin Injection (primarily patients with acromegaly or psoriasis) in patients who had not previously received octreotide, the incidence of biliary tract abnormalities was 63% (27% gallstones, 24% sludge without stones, 12% biliary duct dilatation) Octreotide is a man-made protein that is similar to a hormone in the body called somatostatin. Octreotide lowers many substances in the body such as insulin and glucagon (involved in regulating blood sugar), growth hormone, and chemicals that affect digestion.. Octreotide is used to treat acromegaly.Octreotide is also used to reduce flushing episodes and watery diarrhea caused by cancerous. During these periods, SC Sandostatin injection may be given for a few days at the dosage they were receiving prior to switching to Sandostatin LAR depot; once symptoms resolve; discontinue SC Sandostatin injection; VIPoma. Indicated for treatment of adults with the profuse watery diarrhea associated with VIP-secreting tumors. Bynfezia Pe

Sandostatin® LAR® is a long-acting depot injection form of octreotide. Powder (microspheres for suspension for injection) to be suspended in a vehicle immediately prior to i.m. injection. The pH of the reconstituted suspension is 5-8. 4. CLINICAL PARTICULARS . 4.1 Therapeutic indications Treatment of patients with acromegaly Sandostatin Injection is used for Gastro-entero-pancreatic endocrine tumors, Overproduction of growth hormone, Abnormal growth of hands, Feet and face, Chronic liver disease, Pituitary tumors, Complications following pancreatic surgery, Inflammation of the pancreas gland, Bleeding due to gastro-esophageal veins and other conditions.Sandostatin Injectionmay also be used for purposes not listed.

At-Home Administration Support Sandostatin LAR Depo

  1. Octreotide (Sandostatin) is an analog of naturally occurring somatostatin. It inhibits the secretion of hormones including growth hormone, insulin, glucagon, secretin, motilin, and pancreatic polypeptide. Octreotide (Sandostatin) Uses
  2. d, this is for short-acting Sandostatin (octreotide) not for long-acting Sandostatin LAR. This is a handy chart that diabetics use for injecting insulin
  3. Sandostatin LAR - A Real Pain in the Ass. I've been taking monthly shots of Sandostatin LAR since January 2011. That's 23 times. Over the past 6 months, 3 of the shots have given me Sandostatin lumps, sometimes called hematomas. By definition, a hematoma is a collection of blood outside of a blood vessel. In reality it is a bump.
  4. Sandostatin (octreotide) is a man-made protein that is similar to a hormone in the body called somatostatin. Octreotide lowers many substances in the body such as insulin and glucagon (involved in regulating blood sugar), growth hormone, and chemicals that affect digestion
  5. Octreotide Injections During Lutathera Treatment. You may be getting octreotide injections (shots) as part of your cancer treatment. If you get an octreotide injection too close before your Lutathera infusion, it can make the treatment less effective. Your healthcare provider will give you more information
  6. istered directly by subcutaneous (s.c.) injection or by intravenous (i.v.) infusion after dilution. For further instructions on handling and instructions for dilution of the medicinal product, refer to section 6.6

Sandostatin LAR ® is given by intramuscular injection (IM - into the muscle) under a doctor's supervision. This medication is generally given once every 4 weeks. The preferred site for injection is the hip, because it is painful given into the arm. Sandostatin LAR ® should NOT be given by S.C. or IV routes 1st Floor, BO9/2-2481/12, G.T Road Dilkusha Market, Jalandhar., Jalandhar - 144001, Dist. Jalandhar, Punjab. Verified Supplier. View Mobile Number. Call +91-8048943523. Contact Supplier Request a quote. Novartis Octreotide Acetate 30mg Sandostatin Lar 30 Mg, 1 Injection In A Packet. ₹ 35,000/ Vial Get Latest Price Sandostatin Solution for injection drug summary. Find medication information including related drug classes, side effects, patient statistics and answers to frequently asked questions. Visit cvs.com for more details PK profiles for formulations A, B and C after a single intramuscular injection of 4 mg/kg in male New Zealand rabbits differed markedly from the PK profile of Sandostatin LAR. Conclusions: Clear differences were seen between Sandostatin LAR and formulations A, B and C, including variations in microparticle size, shape and impurity content Octreotide long-acting release (LAR) is a somatostatin analogue designed for once monthly intramuscular injection. As with endogenous somatostatin, octreotide LAR inhibits secretion of growth hormone (GH) as well as various other peptide hormones. In the treatment of acromegaly, octreotide LAR effec

SANDOSTATIN® LAR (octreotide) Prior Auth Criteria Proprietary Information. Restricted Access - Do not disseminate or copy without approval. ©2015, Magellan Rx Management VI. Billing Code/Availability Information Jcode: J2353- Sandostatin LAR Depot (Sandoz GmbH) 10 mg, 20 mg, 30 mg Injection: 1 billable unit = 1 mg NDC: N/A VII. References 1 Octreotide Injection Solution (e.g., Sandostatin) For intravenous (IV) or subcutaneous administration only. Storage: Unopened injection solution is stored at refrigerated temperatures between 2 and 8 degrees C (36 and 46 degrees F) in the outer carton to protect from light Sandostatin Injection / Sandostatin LAR Depot Prior Authorization Request CVS Caremark administers the prescription benefit plan for the patient identified. This patient's benefit plan requires prior authorization for certain medications in order for the drug to be covered. To make an appropriate determination, providing the most accurate. Octreotide long-acting injection is used to control acromegaly, carcinoid tumors, and VIP-omas in people who have been successfully treated with octreotide injection but prefer to receive injections less often. Octreotide injection is in a class of medications called octapeptides

Sandostatin - Chemotherapy Drugs - Chemocar

Octreotide (Sandostatin) Uses, Side Effects & Dosag

Sandostatin LAR Depot 10 mg, 20 mg and 30 mg is indicated in patients in whom initial treatment with Sandostatin Injection has been shown to be effective and tolerated. Generally, patients are started on the short acting drug and switched to the long acting version (some people empirically use Long Acting (LAR) formulation right away) Sandostatin LAR is a long-acting dosage form that maintains all of the clinical and pharmacological characteristics of the immediate-release dosage form with the added feature of slow release of octreotide from the site of injection, reducing the need for frequent administration

Octreotide oral is taken by mouth. Octreotide injection is injected under the skin, into a muscle, or as an infusion into a vein. A healthcare provider will give your first dose and may teach you how to properly use the medication by yourself. Read and carefully follow any Instructions for Use provided with your medicine All injection products: Pain where the shot was given. These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects. Octreotide 4/ J2353. Injection, octreotide, depot form for intramuscular injection, 1 mg. Drugs administered other than oral method, chemotherapy drugs. J2353 is a valid 2021 HCPCS code for Injection, octreotide, depot form for intramuscular injection, 1 mg or just Octreotide injection, depot for short, used in Medical care Octreotide, sold under the brand name Sandostatin among others, is an octapeptide that mimics natural somatostatin pharmacologically, though it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was first synthesized in 1979 by the chemist Wilfried Bauer, and binds predominantly to the somatostatin receptors SSTR2 and SSTR5

Sandostatin Injection : Uses, Side Effects, Interactions

Sandostatin: Uses, side effects, dosage, how to use, and mor

Sandostatin is a short acting version and sandostatin lar is a long acting version. Sandostatin is given by subcutaneous injection (the layer of tissue between the skin and the muscle). It may be necessary to take the shot several times a day. The injection sites should be rotated regularly Sandostatin LAR (octreotide acetate for injectable suspension) is a long-acting dosage form that maintains all of the clinical and pharmacological characteristics of the immediate-release dosage form with the added feature of slow release of octreotide from the site of injection, reducing the need for frequent administration Octreotide immediate-release injection is usually injected 2 to 4 times a day. Octreotide long-acting injection is usually injected once every 4 weeks. Common side effects of octreotide include bile duct abnormalities, fatigue, headache, and abdominal pain. Octreotide can cause dizziness Copay Range$3 - $15. After your deductible has been satisfied, you will enter the Post-Deductible (also called Initial Coverage) stage, where you pay your copay and your plan covers the rest of the drug cost. Copay Range. $2 - $10. In the Donut Hole (also called the Coverage Gap) stage, there is a temporary limit to what Medicare will cover. Sandostatin ® Injection and its generic, octreotide acetate injection and ®2) Sandostatin LAR Depot. Policy/Criteria . It is the policy of health plans affiliated with Centene Corporation ® that Sandostatin Injection, its generic (octreotide acetate injection), and Sandostatin LAR Depot are . medically necessary. when the following.

Octreotide injection is used to treat severe diarrhea and other symptoms that occur with certain intestinal tumors (eg, vasoactive intestinal peptide tumors or VIPomas) or metastatic carcinoid tumors (tumors that has already spread in the body). It does not cure the tumor but it helps the patient feel more comfortable. Octreotide injection is also used to treat a condition called acromegaly. {{configCtrl2.info.metaDescription}} This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies

and octreotide; no study has been large enough or adequately powered to demonstrate superiority of one drug over another.15 Sandostatin® LAR (octreotide) and Somatuline® LA (lanreotide) are administered by intramuscular injection.7,9 Somatuline® Autogel is administered by deep subcutaneous injection.12,13,14 Subcutaneous administration ma Sandostatin injection has been shown to be effective and tolerated. a. Indicated for long-term maintenance therapy in acromegalic patients who have had an inadequate response to surgery and/or radiotherapy, or for whom surgery and/or radiotherapy is not an option. b. Indicated for long-term treatment of the severe diarrhea and flushing episodes. Sandostatin, Sandostatin LAR Pharmacologic class: Somatostatin analog Therapeutic class: Antidiarrheal Pregnancy risk category B Action Suppresses secretion of serotonin, serotonin metabolites, and gastrohepatic peptides, increasing fluid and electrolyte absorption from GI tract. Also suppresses growth hormone, insulin, and glucagon.. Sandostatin Lar 30 mg Powder and Solvent for Suspension for Injection (Novartis Pharmaceuticals UK Limited). MHRA. https://products.mhra.gov.uk. Accessed 18/09/2020. Sandostatin Lar Depot (Novartis Pharmaceuticals Corporation)

Sandostatin LAR is a modified release injection of octreotide. The octreotide is distributed within polymer microspheres. The powder is a white to white with yellowish tint. Diluent The vehicle is a clear, colourless to slightly yellow or brown solution. The pH of the reconstitute Acromegaly,Neuroendocrine (particularly carcinoid) tumour adequately controlled by subcutaneous octreotide. By deep intramuscular injection using depot injection. For Adult. Initially 20 mg every 4 weeks for 3 months then adjusted according to response, increased if necessary up to 30 mg every 4 weeks, to be administered into the gluteal muscle. Sandostatin Injection. Manufacturer: Various Manufacturers / Suppliers. Refrigerated; For your business. To view pricing and availability. Login . Ordering Information; Specifications; Documents/SDS . Ordering Information; Material Description Packaging; 0078-0180-01: SANDOSTATIN 50 MCG / ML AMP 10 X 1 ML. Sandostatin injection Sandostatin LAR Depot octreotide acetate injection (generic) Other _____ 2. What is the patient's diagnosis? Acromegaly Neuroendocrine tumors of the gastrointestinal tract (carcinoid tumors), unresectable or metastatic Neuroendocrine tumors of the thymus (carcinoid tumors), unresectable or metastatic.

Sandostatin (injection) 100mkg 1ml #5: Buy Online on

Sandostatin® LAR Depot (octreotide acetate) for injectable

The immediate-release injection (Sandostatin) is usually injected 2 to 4 times a day. The ong-acting injection (Sandostatin LAR Depot) is usually injected once every 4 weeks. Common side effects of Sandostatin include bile duct abnormalities, fatigue, headache, and abdominal pain. Sandostatin can cause dizziness Sandostatin Injection is used for Inflammation of the pancreas gland, Abnormal growth of hands, Feet and face, Chronic hepatic disease, Pituitary gland tumors, Overproduction of growth hormone, Chronic liver disease, Gastro-entero-pancreatic endocrine tumors, Pituitary tumors, Complications following pancreatic surgery, Bleeding due to gastro-esophageal veins and other conditions.Sandostatin. • J2353- Injection, octreotide, depot form for intramuscular injection, 1 mg: 1 mg = 1 billable unit : Page 5 | SANDOSTATIN® LAR (octreotide) Prior Auth Criteria : Proprietary Information. Restricted Access - Do not disseminate or copy without approval. ©2021, Magellan Rx Management Adults—At first, 20 milligrams (mg) injected into the muscles once every 4 weeks for 2 months. Your doctor will adjust your dose as needed and tolerated. Children—Use and dose must be determined by your doctor. For short-acting injection dosage form (solution): For treatment of acromegaly: Adults—At first, 50 micrograms (mcg) given as a.

Sandostatin Side Effects: Common, Severe, Long Term

Sandostatin® (octreotide acetate) may be administered subcutaneously or intravenously. Subcutaneous injection is the usual route of administration of Sandostatin for control of symptoms. It may be diluted in volumes of 50 - 200 mL and infused intravenously over 15-30 minutes or administered by IV push over 3 minutes Somatuline ® Depot is the 1st & only SSA FDA-approved to treat both adult patients with unresectable, well- or moderately-differentiated, locally advanced or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs) to improve progression-free survival (PFS); and adults with carcinoid syndrome; when used, it reduces the frequency of short-acting somatostatin analog rescue therapy

Sandostatin LAR Injection Manufacturer in Mumbai

Conditions that Sandostatin injection Treat

  1. octreotide acetate depot injection (Sandostatin LAR), schedule patients for imaging at least 1 week after their last injection. Short-acting analogs of somatostatin should be discontinued for 24 hours before imaging, if feasible. Patients should consult their physician before withholding any medication
  2. secreting tumors (2). Octreotide has a longer half-life than somatostatin which allows for intermittent subcutaneous injections rather than a continuous intravenous infusion (1,2). Treatment with octreotide is proposed to decrease nutrient and electrolyte losses and promote fistula closure (1). Benefits of thes
  3. Acromegaly: Octreotide acetate injection is indicated to reduce blood levels of growth hormone and IGF-I (somatomedin C) in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection, pituitary irradiation, and bromocriptine mesylate at maximally tolerated doses.The goal is to achieve normalization of growth hormone and IGF-I (somatomedin C) levels
  4. Sandostatin Injection . the varied demand of our customers in an appropriate manner. Our professionals are highly experienced and very well aware of the trends ruling the market. They ensure that the customers associated with us are served in best possible manner. one can also avail our range at reasonable prices. Features: Easily availabl
  5. Octreotide acetate works to reduce the absorption of cyclosporine through the intestinal walls. As a result, the patient may experience transplant rejection. A single octreotide acetate injection will increase the bioavailability of bromocriptine, a drug for managing Parkinson disease

Dosing & Administration for Sandostatin LAR Depo

Octreotide is an octapeptide that mimics endogenous somatostatin. Somatostatin is released by cells in the pyloric antrum, the pancreas, and the duodenum. It has an overall inhibitory effect on secretion of multiple hormones, reducing gut motility and gastric emptying, and decreasing splanchnic blood flow. Octreotide contains the active moiety. Get listings of sandostatin injection dealers, distributors & exporters. Listed dealers are offering sandostatin injection as per your requirements at low prices Sandostatin LAR Depot injection for other disease states: Gastroenteropancreatic neuroendocrine tumors, functional, vasoactive intestinal peptide-secreting (VIPomas) Acromegaly High output fistula not responding to octreotide SC Implications for Nursing a. Sandostatin Injection/octreotide acetate injection (subcutaneous or intravenous use): i. For the brand formulation, member has a contraindication to, or has tried and has an intolerance to, the generic formulation (octreotide acetate injection); ii. Upward dose titration does not exceed 1500 mcg/day in divided doses; b J2354. Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg. Drugs administered other than oral method, chemotherapy drugs. J2354 is a valid 2021 HCPCS code for Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg or just Octreotide inj, non-depot for short, used in.

  1. SANDOSTATIN prescription and dosage sizes information for physicians and healthcare professionals. Pharmacology, adverse reactions, warnings and side effects
  2. OCTREOTIDE (ok TREE oh tide) is used to reduce blood levels of growth hormone in patients with a condition called acromegaly. This medicine also reduces flushing and watery diarrhea caused by certain types of cancer. This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions
  3. Immediate-release Sandostatin injection. It's given as a subcutaneous injection or as an intravenous injection (an injection into a vein). A healthcare provider can teach you how to give these.
  4. imize irritation, use alternate sides for subsequent injections
Sandostatin injection : Uses, Side Effects, Interactions

Sandostatin LAR (Octreotide Acetate Injection): Uses

  1. Octreotide has two formulations. For purposes of clarity, trade names will be used for discussion. Sandostatin® is a short acting version and Sandostatin LAR® is a long acting version. Sandostatin® is given by subcutaneous injection (S.C. - the layer of tissue between the skin and the muscle)
  2. Sandostatin solution for injection is a clear and colourless liquid supplied in boxes of 5 ampoules. The solution is filled into a 1 mL colourless glass ampoule with two colour code rings and a.
  3. The long-acting formulation, Sandostatin LAR, is octreotide contained in microspheres, which allow the drug to be slowly released into the body over a 4-week period. This allows the patient to receive only one injection a month at their doctor's office. This injection is given into the muscle (intramuscularly or IM)
  4. Learn proper technique for SC injection if self-medication is required. Note: Preferred sites for SC injections of octreotide are the hip, thigh, and abdomen. Multiple injections at the same SC injection site within short periods of time are not recommended. This is to avoid irritating the area
  5. I was on sandostatin injections when I came home from the hospital after they did the Whipple procedure. I was still on the feeding tube when I had it. Actually the home nurse over dosed me with it, I was suppose to have .003 and she gave me 3.00, the side affects was stomach cramps and I lost some hair
  6. EAST HANOVER, N.J., Jan. 13 /PRNewswire/ — Sandostatin LAR (R) Depot (octreotide acetate suspension for injection) demonstrated antitumor benefit in patients with metastatic neuroendocrine tumors (NETs) of the midgut, according to interim data presented today at the 2009 Gastrointestinal Cancer Symposium of the American Society of Clinical.
  7. istration by deep subcutaneous (intrafat) or intravenous (IV) injection. Octreotide acetate, known chemically as L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1.
Sandostatin Injection in Mumbai - Manufacturers andSandostatin Injection - Latest Price, Dealers & RetailersSandostatin Injection Manufacturers & OEM Manufacturer in

SANDOSTATIN® Injection therapy resulted in worsening of CHF with improvement when drug was discontinued. Confirmation of a drug effect was obtained with a positive rechallenge (see ADVERSE REACTIONS). Endocrine and Metabolism Glucose Metabolism SANDOSTATIN® therapy is occasionally associated with mild transient hypo- or hyperglycemi The octreotide levels after one injection (day 28) are, in turn, less than octreotide levels after the second or even third injections (days 56 and 84). Thus it takes on average three monthly LAR injections for the octreotide levels to stabilize at what is called steady state. However, if one needs to get off of LAR therapy, the same. SANDOSTATIN® (octreotide acetate injection) This leaflet is part III of a three-part Product Monograph published when SANDOSTATIN® was approved for sale in Canada and is designed specifically for Consumers. This leaflet is a summary and will not tell you everything about SANDOSTATIN®. Contact you Sandostatin Injection Sandostatin LAR Depot Octreotide acetate injection (generic) Other _____ 2. What is the patient's diagnosis? Acromegaly Meningioma Thymomas and thymic carcinoma Neuroendocrine tumors of the gastrointestinal tract (carcinoid tumors